PAPER Qi C, Hasegawa M, Takao M, Sakai M, Sasaki M, Mizutani M, Akagi A, Iwasaki Y, Miyahara H, Yoshida M, Scheres SH, Goedert M
SEARCH RESULTS
331254 RESULTS
PAPER Concepcion FA, Ekstrom NA, Khan MN, Estes OO, Poolos NP
Progressive Dysregulation of Tau Phosphorylation in an Animal Model of Temporal Lobe Epilepsy.
Neuroscience. 2023 Jul 1;522:42-56. Epub 2023 May 2 PubMed: 37142182PAPER Nakamura R, Tohnai G, Nakatochi M, Atsuta N, Watanabe H, Ito D, Katsuno M, Hirakawa A, Izumi Y, Morita M, Hirayama T, Kano O, Kanai K, Hattori N, Taniguchi A, Suzuki N, Aoki M, Iwata I, Yabe I, Shibuya K, Kuwabara S, Oda M, Hashimoto R, Aiba I, Ishihara T, Onodera O, Yamashita T, Abe K, Mizoguchi K, Shimizu T, Ikeda Y, Yokota T, Hasegawa K, Tanaka F, Nakashima K, Kaji R, Niwa JI, Doyu M, Terao C, Ikegawa S, Fujimori K, Nakamura S, Ozawa F, Morimoto S, Onodera K, Ito T, Okada Y, Okano H, Sobue G, Japanese Consortium for Amyotrophic Lateral Sclerosis research (JaCALS) study group
Genetic factors affecting survival in Japanese patients with sporadic amyotrophic lateral sclerosis: a genome-wide association study and verification in iPSC-derived motor neurons from patients.
J Neurol Neurosurg Psychiatry. 2023 Oct;94(10):816-824. Epub 2023 May 4 PubMed: 37142397PAPER Ivanova O, Martínez-Nicolás I, Meilán JJ
Speech changes in old age: Methodological considerations for speech-based discrimination of healthy ageing and Alzheimer's disease.
Int J Lang Commun Disord. 2023 May 4; PubMed: 37140204PAPER Singh A, Ansari VA, Mahmood T, Ahsan F, Wasim R, Maheshwari S, Shariq M, Parveen S, Shamim A
Emerging Nanotechnology for the Treatment of Alzheimer's Disease.
CNS Neurol Disord Drug Targets. 2023 May 1; PubMed: 37138478PAPER Barbero Mazzucca C, Cappellano G, Chiocchetti A
Nutrition, immunity and aging: current scenario and future perspectives in neurodegenerative diseases.
CNS Neurol Disord Drug Targets. 2023 May 2; PubMed: 37138438PAPER Sharma B, Beaudin AE, Cox E, Saad F, Nelles K, Gee M, Frayne R, Gobbi DG, Camicioli R, Smith EE, McCreary CR
Brain iron content in cerebral amyloid angiopathy using quantitative susceptibility mapping.
Front Neurosci. 2023;17:1139988. Epub 2023 Apr 17 PubMed: 37139529PAPER Chen CH, Khnaijer MK, Beaudin AE, McCreary CR, Gee M, Saad F, Frayne R, Ismail Z, Pike GB, Camicioli R, Smith EE
Subcortical volumes in cerebral amyloid angiopathy compared with Alzheimer's disease and controls.
Front Neurosci. 2023;17:1139196. Epub 2023 Apr 17 PubMed: 37139517PAPER Creese B, Arathimos R, Aarsland D, Ballard C, Brooker H, Hampshire A, Corbett A, Ismail Z
Late-life onset psychotic symptoms and incident cognitive impairment in people without dementia: Modification by genetic risk for Alzheimer's disease.
Alzheimers Dement (N Y). 2023;9(2):e12386. Epub 2023 Apr 30 PubMed: 37139261PAPER Yesantharao L, Cai Y, Schrack JA, Gross AL, Wang H, Bilgel M, Dougherty R, Simonsick EM, Ferrucci L, Resnick SM, Agrawal Y
Sensory impairment and beta-amyloid deposition in the Baltimore longitudinal study of aging.
Alzheimers Dement (Amst). 2023;15(2):e12407. Epub 2023 Apr 30 PubMed: 37139098PAPER Qin Z, Liu Z, Lu Y, Zhu P
[Research on classification method of multimodal magnetic resonance images of Alzheimer's disease based on generalized convolutional neural networks].
Sheng Wu Yi Xue Gong Cheng Xue Za Zhi. 2023 Apr 25;40(2):217-225. PubMed: 37139751PAPER Moyaert P, Padrela BE, Morgan CA, Petr J, Versijpt J, Barkhof F, Jurkiewicz MT, Shao X, Oyeniran O, Manson T, Wang DJ, Günther M, Achten E, Mutsaerts HJ, Anazodo UC
Imaging blood-brain barrier dysfunction: A state-of-the-art review from a clinical perspective.
Front Aging Neurosci. 2023;15:1132077. Epub 2023 Apr 17 PubMed: 37139088PAPER Li L, Zhang Q, Yang D, Yang S, Zhao Y, Jiang M, Wang X, Zhao L, Liu Q, Lu Z, Zhou X, Gan Y, Wu C
Tooth loss and the risk of cognitive decline and dementia: A meta-analysis of cohort studies.
Front Neurol. 2023;14:1103052. Epub 2023 Apr 17 PubMed: 37139053PAPER Sahu PP, Tseng P
Gamma sensory entrainment for cognitive improvement in neurodegenerative diseases: opportunities and challenges ahead.
Front Integr Neurosci. 2023;17:1146687. Epub 2023 Apr 17 PubMed: 37138796PAPER Dane TL, Gill AL, Vieira FG, Denton KR
Reduced C9orf72 expression exacerbates polyGR toxicity in patient iPSC-derived motor neurons and a Type I protein arginine methyltransferase inhibitor reduces that toxicity.
Front Cell Neurosci. 2023;17:1134090. Epub 2023 Apr 17 PubMed: 37138766Current Filters
No filters selected